BSEResult59m ago · 13 Aug 2026, 04:15 pm
Unaudited Financial Results for the quarter ended 30th June, 2026
3B BlackBio Dx Ltd · 532067
✦ AI SummaryResults
3B BlackBio Dx Ltd has announced unaudited financial results for the quarter ended 30th June, 2026, with revenue from operations at ₹2294.52 crores and profit for the period at ₹4,131.21 crores.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
3B BlackBio Dx Ltd - 532067 - Unaudited Financial Results For The Quarter Ended 30Th June, 2026
Attachments (1)
📄pdf
Download →
4a471082-4786-47a9-804d-9cd82b4f285f.pdf
View document text
(Formerly – Kilpest India Limited)
Ref. No.P-66/2026-27/26
August 13, 2026
The Relationship Manager,
Department of Corporate Relations
BSE Limited,
P.J. Towers, Dalal Street
Fort, MUMBAI – 400 001
Subject: Outcome of Board Meeting held on Thursday, 13th August, 2026
Pursuant to Regulations 30 & 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (Listing Regulations),we wish to inform you that
the Board of Directors of the Company at its Meeting held today i.e. 13th August,
2026, has inter-alia, considered and approved the following:
1. Financial results:
Unaudited Standalone and Consolidated Financial Results of the Company for the
quarter ended on 30th June 2026. The same has also been reviewed by the Audit
Committee in its meeting held today.
Further, Baheti & Co., Statutory Auditors of the Company have carried out the
Limited Review of the Unaudited Standalone and Consolidated Financial Results for
the quarter ended 30th June 2026 and the Board has also taken on record their
Limited Review Reports on the said Financial Results.
A copy of the Financial Results along with Limited Review Report for the quarter
ended 30th June, 2026, as required under Regulation 33 of the Listing Regulations, is
attached.
2. Appointment of M/s Sanjay Kasliwal & Associates, Cost Accountants & Social
Auditor, Bhopal as Cost Auditor of the Company for the FY 2026-27;
The said appointment of M/s. Sanjay Kasliwal & Associates is in compliance with
Section 148 of the Companies Act, 2013 and other applicable provisions, if any, read
with Companies (Cost Records and Audit) Rules, 2014. The remuneration payable to
M/s Sanjay Kasliwal & Associates shall be placed before the shareholders for
ratification at the ensuing Annual General Meeting.
Regd. Office & Factory : 7-C | Industrial Area | Govindpura | Bhopal – 462023 | (M.P.) | INDIA CIN : L24211MP1972PLC001131
Ph.: 91-755-2586536, 2586537 Email : info@kilpest.com Visit us at : www.kilpest.com
(Formerly – Kilpest India Limited)
The disclosure pursuant to SEBI Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as
Annexure -A
The Meeting of the Board of Directors held today commenced at 3:00 P.M. and
concluded at 3:50 P.M.
Kindly take the same on your records.
Thanking You,
For 3B BlackBio Dx Limited (Formerly, Kilpest India Limited)
Nikhil Kuber Dubey
Whole Time Director
DIN: 00538049
38 BlackBi
(FormerlY
AN N EXU RE-A
DISCLOSURE AS PER REGULATION 30 OF LISTING REGULATIONS READ WITH SEBI
MA5TER cTRCULAR No . Ho/49lt4/t4(7)2025-cFD-PoD2lrl3762/2026 dated IANUARY
30, 2026
Name M/s. Sanjay Kasliwal & Associates
Reason for Appointment
change
viz.
appointment, re-
apBeintment
resigffiti€ft
erotj+erwise
Appointed as Cost Auditor for FY 2026-27 at the Board meetlng
held on 13th August, 2026, to issue Cost Audit Report as per the
provisions of the ComPanies Act,20t3
Brief Profile Accountants Social
(in case of has experience and
he firm also
appointment) Provides
Records as prescribed
under the Companies (Cost Records and Audit) Rules, 2014 and
certification as regards maintenance of Cost Records by the
Comoa nv.
Disclosure of NA
relationships
between
irectors
d ( in
case
appointment
ofao
director)
For38 Bla
38 BLACKBIO DX LIMITED
REGD.OFFICE: 7-C, INDUSTRIAL AREA,GOVINDPURA, BHOP AL-462 023
Cl N :1242 1 1M P1972 PLC001- L3 1
(Rs. In Lakhs)
S.No. PARTICULARS QUARTER ENDED YEAR ENDED
30-06-2026 3L-03-2026 30-05-202s 3L-03-2026
(U naudited) (nudited) (Unaudited) (Audited)
Revenue from operations 2294.52 2463.01 2035.7r 9727.50
tl Other income 530.27 130.33 431..42 141,6.20
Total Income (l + ll) 2824.79 2s93.34 2467.L3 LLL43,7O
Expenses:
Cost of materials consumed 493.25 578.96 5 19.70 2345.1,6
Pu rchases of Stock-i n-Trade 0,00 0.00 0.00 0,00
Changes in inventories of finished goo€llelk-ift (2e.e4) 29.80 (s.s7) 11.69
Employee benefits expenses 182.86 225.92 148.8 1 757.93
Finance costs 0.02 0.41 0.80 4.39
Depreciation and amortization expense 23.50 29.3r 21.50 94.31,
Other expenses 31.9.78 500.15 2r4.35 1294.54
Total expenses (lV) 989.47 1364.55 899.19 4s08.02
Profit/(loss) before exceptional items and tax (lll 1835.32 t228.79 1.567.94 653s.68
Exceptional items 0.00 0.00 0.00 0.00
Profit before tax (V vt) 183s.32 L228.79 ts67.94 563s.68
Tax expense:
(1) Current tax 424.1,r 395.64 3 21,90 1615,49
(2) Deferred tax 0.00 88.s0 0.00 88.50
X Profit (Loss) for the period (Vll-Vlll) L4LL.2T 744.65 L246.O4 493r..69
Other Comprehensive I ncome/(loss) 0.00 0.00 0,00 0.00
Total Comprehensive Income for the period
(rx+x) L4tL,2L 744.65 L246.04 493L.69
X Paid-up Equity Share capital 856.84 8s6.84 856.84 856,84
Reserve excluding Revaluation Reserves as per
X balance sheet of previous year 31,044.75 26421,.76 26421.16 2642L.76
XV Earnings per equity share:
(1) Basic 16.41 8,69 1,4.54 57.56
(2) Diluted 1,6.47 8.69 1,4.54 5t.56
FOR AND ON BEHALF OF THE BOARD
PLACE: BHOPAL KHIL KUBER DUBEY
DATE :1,3/08/2026 WHOLE TIME DIRECTOR
DIN:00538049
JUNE. 2026
1. T Rh ee qu a irb eo mv ee n tr se )s Ru elt gs u a lar te io na ss , 2p 0e 1r 5R aeg i u ala mti eo nn d e3 d3 ao nf d t hh ae v es E bB eeI n( L tais kti en ng oo nb li rg ea ct oio rdn .s , b yu 1 th9 e D Bis oc alo rs du r oe f
Directors at its n1.6ting held on August 13, 2026 after being reviewed by the Audit Committee'
2. The Company,s Agrochemical Business is seasonal in nature and the performance can be impacted by
weather conditions and cropping pattern.
3 T Sh tae nse d af rin da sn (c Ii nal d r Aes Su ) lt as s h pa rv ee s cb re iben e dp r ue np da ere r d s eIn ct ia oc nc o 1r 3d 3an oce f Cw oi mth p t ah ne ie r se q Au cir te , m 2e 0n t3ts reo af dIn wdi ia thn A Cc oc mo pu an nti in eg s
(Indian Accounting Standards) Rules, 2ol5 as amended'
4 The figures for the quarter ended March 3t, 2026 are the balancing figures between audited figures
for the full financial year ended March 31, 2026 and unaudited figures for the nine months ended
December 3L,202s, being the date of the end of the third quarter of the financial year/ which were
subjected to limited review.
5. All the figures of financials have been rounded off to nearest lakh in rupees.
6. There is an increase in other expenses by 3o/o which is mainly because of expenditure incurred
towards IVDR regulatory registration process and participation in international trade fair.
previous period/year figures have been regrouped / rearranged, wherever deemed necessary'
B The results of the company are available for investors at www.kilpest.com and www'bseindia.com'
Limited Review:
The Limited Review, as required under Regulation 33 of the SEBI (Listing obligations and Disclosure
Requirements) Regulations,20l5 as ameMed, has been completed and the related Report shall be
forwarded to the stock Exchanges. This Report does not have any impact on the above "Results and
Notes" for the quarter ended June 30,2026 which needs to be explained.
FOR AND ON BEHALF OF THE BOARD
NIKHI
BER DUBEY
PLACE: BHOPAL
DATE L3/08/2026 LE TIME DIRECTOR
DIN: 00538049
BAHETI & CO,
CH ART E R E D ACCO U NTA/VIS
24,M.P. NAGAR ZONE II
BHOPAL 4620TT
6314r,4251535
Independent Auditor's Review Report on the Quarterly Unaudited Standalone
Financial Results of the Company Pursuant to the Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2OL5, as
amended
Review RePort to
The Board of Directors of
3B BIackBio Dx Limited (Formerly, Kilpest India Limited)
1,. We have reviewed the accompanying statement of unaudited standalone
financial results of 3B BlackBio Dx Limited (Formerly, Kilpest India Limited)
(the ,,Company") for the quarter ended June 30, 2026 (the "statement")
attached herewith, being submitted by the Company pursuant to the
requirements of Regulation 33 of'the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2O!5, as amended (the "Listing
Regulations").
2. The Company's Management is responsi
[Showing first 8,000 characters — download PDF for full document]